Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 2
1952 1
1953 1
1954 1
1955 2
1956 1
1958 2
1959 3
1960 9
1961 10
1962 9
1963 22
1964 24
1965 23
1966 28
1967 33
1968 49
1969 57
1970 24
1971 40
1972 57
1973 86
1974 63
1975 72
1976 58
1977 82
1978 53
1979 64
1980 50
1981 50
1982 64
1983 42
1984 55
1985 45
1986 66
1987 41
1988 43
1989 51
1990 57
1991 56
1992 63
1993 63
1994 81
1995 84
1996 68
1997 67
1998 113
1999 92
2000 96
2001 124
2002 158
2003 146
2004 126
2005 144
2006 114
2007 75
2008 88
2009 76
2010 73
2011 62
2012 61
2013 69
2014 68
2015 53
2016 53
2017 44
2018 49
2019 38
2020 28
2021 24
2022 26
2023 20
2024 18
2025 24
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,860 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean porogen (2,080 results)?
A review of estrogens used in menopausal hormone therapy.
Soltani A, Voedisch AJ. Soltani A, et al. Curr Opin Obstet Gynecol. 2026 Apr 1;38(2):86-93. doi: 10.1097/GCO.0000000000001090. Epub 2026 Feb 2. Curr Opin Obstet Gynecol. 2026. PMID: 41621089 Review.
PURPOSE OF REVIEW: To provide an overview of endogenous and therapeutic estrogens, their receptor biology, clinical applications, and evolving safety considerations, with emphasis on how estrogen type, timing, and route of administration influence outcomes in menopausal ho …
PURPOSE OF REVIEW: To provide an overview of endogenous and therapeutic estrogens, their receptor biology, clinical applications, and …
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.
Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Kantarci K, et al. Alzheimers Dement. 2026 Feb;22(2):e71067. doi: 10.1002/alz.71067. Alzheimers Dement. 2026. PMID: 41618732 Free PMC article. Clinical Trial.
METHODS: Recently menopausal women with good cardiovascular health were randomized to oral conjugated equine estrogens (oCEE) or transdermal 17beta-estradiol (tE2) and micronized progesterone, or placebo for 4 years. ...
METHODS: Recently menopausal women with good cardiovascular health were randomized to oral conjugated equine estrogens (oCEE) …
AI-Driven Enzyme Engineering: Emerging Models and Next-Generation Biotechnological Applications.
Khan MF, Khan MT. Khan MF, et al. Molecules. 2025 Dec 22;31(1):45. doi: 10.3390/molecules31010045. Molecules. 2025. PMID: 41515342 Free PMC article. Review.
Machine learning and deep learning models such as AlphaFold2, RoseTTAFold, ProGen, and ESM-2 accurately predict enzyme structure, stability, and catalytic function, facilitating rational mutagenesis and optimisation. ...
Machine learning and deep learning models such as AlphaFold2, RoseTTAFold, ProGen, and ESM-2 accurately predict enzyme structure, sta …
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024.
Vogl UM, Merler S, Angrisani A, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small EJ, Smith MR, Sweeney CJ, Tombal B, Zilli T, Herrmann K, Omlin A, Gillessen S; APCCC 2024 expert panel. Vogl UM, et al. Eur J Cancer. 2026 Jan 17;233:116131. doi: 10.1016/j.ejca.2025.116131. Epub 2025 Nov 21. Eur J Cancer. 2026. PMID: 41407614 Free article. Review.
Underestimated risks of conjugated estrogens in wastewater: New insights into transformation products and mass balance.
Yu Q, Hu X, Bao Y, Zhang W, Zhang C, Ding X, Ren H, Geng J. Yu Q, et al. Water Res. 2026 Feb 15;290:125110. doi: 10.1016/j.watres.2025.125110. Epub 2025 Dec 6. Water Res. 2026. PMID: 41380512
Neglected conjugated estrogens (CEs) may lead to significantly increased ecological risks following transformation. ...Transformation networks revealed extensive interconnections among natural CEs, with free estrogens (FEs) and hydroxylated TPs serving as cen …
Neglected conjugated estrogens (CEs) may lead to significantly increased ecological risks following transformation. ...Transfo …
Then and Now: What We Have Learned From the WHI.
Lambrinoudaki I, Armeni E, Milli N, Anagnostis P. Lambrinoudaki I, et al. J Clin Endocrinol Metab. 2026 Mar 17;111(4):e974-e994. doi: 10.1210/clinem/dgaf638. J Clin Endocrinol Metab. 2026. PMID: 41379766 Free PMC article. Review.
RESULTS: WHI data reveal that both combined conjugated equine estrogen-medroxyprogesterone acetate (CEE-MPA) and CEE-only therapy significantly reduce hip, vertebral, and total fracture risk, with further skeletal protection from calcium and vitamin D co-administration. .. …
RESULTS: WHI data reveal that both combined conjugated equine estrogen-medroxyprogesterone acetate (CEE-MPA) and CEE-only therapy sig …
Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study.
James TT, Dowling NM, Ferrer Simó C, Salazar H, Van Hulle CA, Ennis G, Johnson AL, Wyman MF, McLester-Davis LWY, Gooding DC, Fischer B, Bouges S, Umucu E, Kara F, Kling JM, Manson JE, Brinton EA, Cedars MI, Lobo RA, Neal-Perry G, Santoro NF, Naftolin F, Harman SM, Pal L, Miller VM, Kantarci K, Gleason CE. James TT, et al. Menopause. 2026 Feb 1;33(2):151-160. doi: 10.1097/GME.0000000000002666. Menopause. 2026. PMID: 41186575 Free PMC article. Clinical Trial.
METHODS: KEEPS randomized 727 women (ages 42-58) who were <36 months postnatural menopause to oral conjugated equine estrogens (o-CEE), transdermal 17-beta-estradiol (t-E2), or placebo for 48 months. ...
METHODS: KEEPS randomized 727 women (ages 42-58) who were <36 months postnatural menopause to oral conjugated equine estrogens …
3,860 results